Renaissance Technologies
ORKA

Renaissance Technologies’s Oruka Therapeutics ORKA Stock Holding History

Renaissance Technologies’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,900
Closed -$156K – 4029
2025
Q2 		$156K Sell
13,900
-21,900
-61% -$228K ﹤0.01% 3215
2025
Q1 		$367K Buy
+35,800
New +$447K ﹤0.01% 2854
2024
Q3 		– Sell
-6,092
Closed -$280K – 3962
2024
Q2 		$280K Buy
6,092
+617
+11% +$24.6K ﹤0.01% 2933
2024
Q1 		$116K Buy
5,475
+700
+15% +$13.9K ﹤0.01% 3342
2023
Q4 		$97K Buy
4,775
+542
+13% +$12.2K ﹤0.01% 3311
2023
Q3 		$102K Buy
4,233
+525
+14% +$12.9K ﹤0.01% 3238
2023
Q2 		$90K Buy
3,708
+400
+12% +$9.85K ﹤0.01% 3502
2023
Q1 		$79K Buy
3,308
+375
+13% +$9.88K ﹤0.01% 3559
2022
Q4 		$83K Buy
2,933
+141
+5% +$3.61K ﹤0.01% 3681
2022
Q3 		$69K Buy
2,792
+84
+3% +$2.37K ﹤0.01% 3683
2022
Q2 		$81K Buy
+2,708
New +$76.5K ﹤0.01% 3899
2021
Q1 		– Sell
-17,125
Closed -$824K – 3782
2020
Q4 		$824K Buy
17,125
+13,932
+436% +$694K ﹤0.01% 2602
2020
Q3 		$169K Sell
3,193
-3,664
-53% -$258K ﹤0.01% 3140
2020
Q2 		$545K Sell
6,857
-4,251
-38% -$278K ﹤0.01% 2844
2020
Q1 		$372K Sell
11,108
-773
-7% -$42K ﹤0.01% 2894
2019
Q4 		$814K Buy
11,881
+3,540
+42% +$227K ﹤0.01% 2720
2019
Q3 		$535K Buy
8,341
+1,634
+24% +$120K ﹤0.01% 2849
2019
Q2 		$589K Buy
6,707
+2,533
+61% +$227K ﹤0.01% 2927
2019
Q1 		$337K Buy
4,174
+384
+10% +$34.1K ﹤0.01% 3055
2018
Q4 		$273K Buy
3,790
+686
+22% +$85.1K ﹤0.01% 3056
2018
Q3 		$375K Buy
3,104
+1,163
+60% +$150K ﹤0.01% 2939
2018
Q2 		$233K Sell
1,941
-529
-21% -$62.1K ﹤0.01% 3039
2018
Q1 		$266K Buy
2,470
+1,870
+312% +$502K ﹤0.01% 3114
2017
Q4 		$175K Sell
600
-496
-45% -$144K ﹤0.01% 3158
2017
Q3 		$272K Buy
1,096
+844
+335% +$300K ﹤0.01% 2930
2017
Q2 		$130K Buy
252
+110
+77% +$57.4K ﹤0.01% 3056
2017
Q1 		$78K Buy
142
+53
+60% +$29.6K ﹤0.01% 3104
2016
Q4 		$55K Buy
+89
New +$47.4K ﹤0.01% 3160
2014
Q1 		– Sell
-407
Closed -$1.03M – 3045
2013
Q4 		$1.03M Buy
407
+345
+556% +$796K ﹤0.01% 2058
2013
Q3 		$150K Buy
62
+52
+520% +$108K ﹤0.01% 2636
2013
Q2 		$19K Buy
+10
New +$30.5K ﹤0.01% 2739

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Renaissance Technologies's ORKA Position: Q3 2025 in Review

Renaissance Technologies sold out of Oruka Therapeutics (ORKA) in Q3 2025, closing a stake of 13,900 shares — an estimated $156K sold.

Renaissance Technologies first reported a position in ORKA in Q2 2013 and held it in 31 quarters. The position peaked at $1.03M in Q4 2013. 105 funds tracked by Wall St. Rank hold ORKA as of Q3 2025.

  • Renaissance Technologies reported no remaining Oruka Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 13,900 Oruka Therapeutics shares in Q3 2025, an estimated $156K.
  • Renaissance Technologies first reported a position in Oruka Therapeutics in Q2 2013 and held it in 31 quarters.
  • Renaissance Technologies's Oruka Therapeutics position peaked at $1.03M in Q4 2013.
  • 105 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.